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We examined the effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) on viral DNA, RNA, protein,
and enzyme synthesis in HeLa cells infected with herpes simplex virus type 1 and type 2. DHPG inhibited virus
DNA synthesis in a dose-dependent fashion. This inhibition was not due to the lack of deoxynucleoside
triphosphates which are required for DNA synthesis. This compound has no apparent effect on early and late
viral RNA synthesis, viral protein synthesis, or viral thymidine kinase, DNA polymerase, and DNase induction
in virus-infected cells.
In recent years, several nucleoside analogs have been
found to have selective antiherpesvirus activities. Among
these, a new guanosine analog, 9-(1,3-dihydroxy-2-propoxy-
methyl)guanine (DHPG), was shown to have a broad and
unique spectrum of antiherpesvirus activity at concentra-
tions which were not toxic to several mammalian cells in
culture (1, 4, 15, 20, 23, 24). Its antiviral activity in vivo was
also demonstrated (8, 16, 23). In herpes simplex virus
(HSV)-infected cells, DHPG was phosphorylated to DHPG
monophosphate (DHPGMP) by virus-induced thymidine ki-
nase (1, 4, 23) and further phosphorylated to DHPG diphos-
phate (DHPGDP) and DHPG triphosphate (DHPGTP) by
cellular kinases (2, 8). DHPGTP could substitute for dGTP
and be incorporated into DNA by virus-induced DNA poly-
merase in an efficient manner. The incorporation of DHPG
could slow down DNA chain elongation. Furthermore,
DHPG-terminated DNA could act as a potent inhibitor of
virus-induced DNA polymerase by competing with activated
DNA template (9). Early studies by other investigators
indicated that DHPG inhibited viral DNA synthesis (23), but
it was unclear whether DHPG had a selective effect upon the
synthesis of other viral macromolecules such as protein or
RNA. With the aid of newly developed techniques, we
examined the effects of DHPG on viral macromolecule
synthesis, and our results are reported in this communica-
tion.
MATERIALS AND METHODS
DHPG and [3H]DHPG were kindly provided by Syntex
(USA) Inc., Palo Alto, Calif. All other radioactive materials
were purchased from ICN Pharmaceuticals, Inc., Irvine,
Calif. Deoxynucleosides and deoxynucleotides were pur-
chased from P. L. Biochemicals, Inc., Milwaukee, Wis.
RPMI 1640 medium, Joklik modified medium, fetal calf
serum, and horse serum were purchased from GIBCO
Laboratories, Grand Island, N.Y. DNA polymerase (Esche-
richia coli) was purchased from Boehringer Mannheim Bio-
chemicals, Indianapolis, Ind. Nitrocellulose paper (BA85,
0.45 ,um) was purchased from Schleicher & Schuell, Inc.,
Keene, N.H. HSV type 1 (HSV-1) and type 2 (HSV-2)
antisera were purchased from DAKO Immunoglobulins,
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Santa Barbara, Calif. All chemicals used were reagent grade
or better.
Cells and virus. Cells were grown at 37°C in RPMI 1640
medium containing 100 p.g of kanamycin per ml and supple-
mented with 5% horse serum or 5% fetal calf serum for HeLa
S3 or Vero cells, respectively. All cultures were found to be
mycoplasma free when tested by the 4,6-diamidino-2-phenyl-
indole fluorescence technique (21). HSV-1 (strain KOS) and
HSV-2 (strain 333) were maintained as previously described
(3).
Preparation of samples for isopycnic gradient centrifuga-
tion. HeLa S3 cells were plated in a six-well dish at 106 cells
per 10-cm2 well. Once the cells were attached to the dish, the
growth medium was removed and replaced with Joklik
modified (low-phosphate) medium containing 1% fetal calf
serum. HSV-1 (KOS) was added at 3 PFU per cell and
incubated at 37°C for a 1-h adsorption period. The medium
containing virus was then removed, and the cell layer was
washed with phosphate-buffered saline (PBS) (0.14 M NaCl,
4.0 mM KCI, 0.5 mM Na2HPO4, 0.15 M KH2PO4) and
replaced with 1 ml of medium containing various concentra-
tions of DHPG. After a 2-h incubation period, 25 ,uCi of
32P04 was added to each well. At 8 h after virus infection the
samples were harvested by scraping the cells into the
medium and centrifuging at 2,000 rpm for 10 min. The cell
pellets were washed two times in cold PBS and lysed
overnight in buffer (10 mM Tris hydrochloride, pH 7.9, 1 mM
EDTA, 100 mM NaCl, 0.5% Sarkosyl, and 1% sodium
dodecyl sulfate [SDS]) containing 1 mg of proteinase K per
ml. This was followed by isopycnic gradient centrifugation
as previously described (22).
Preparation of cytoplasmic RNA. HeLa S3 cells were
infected with HSV-1 (KOS) at 5 PFU per cell. After incuba-
tion for 1 h the virus was removed and the cell layer was
washed with PBS. Growth medium was added to each flask
with or without DHPG (5 ,uM). One treated and one control
flask were harvested at 0, 3, and 6 h after viral infection. A
rubber policeman was used to scrape the cell layer into the
medium, and the cells were pelleted by centrifugation at
2,000 rpm. All subsequent steps were performed on ice with
sterile equipment, glassware, and reagents to prevent enzy-
matic breakdown of the RNA. The cell pellet was resus-
pended in ice-cold PBS and recentrifuged. After decanting
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the supernatant, each pellet (approximately 0.1 ml) was
suspended in 3.5 ml of PBlo0 buffer (2.5 mM Tris hydrochlo-
ride, pH 7.1, 2.5 mM NaCl, 1 mM MgCI2, 5% sucrose)
containing 1 mg of sodium heparin per ml and homogenized
in a Dounce homogenizer by six strokes with a B-type
pestle. The homogenate was transferred to a Corex tube,
mixed with 0.1 volume of Triton-DOC solution (10% Triton
X-100 + 10% sodium deoxycholate), and centrifuged at
10,000 rpm for 10 min. The supernatant containing the
cytoplasmic RNA was deproteinated at 25°C by shaking for
15 min with 0.1 volume of 1Ox SET buffer (100 mM Tris
hydrochloride, pH 7.1, 50 mM EDTA, 10% [wt/vol] SDS) 0.5
volume of phenol, and 0.5 volume of chloroform. After
centrifugation at 10,000 rpm for 15 min the aqueous phase
was removed and brought to a final concentration of 0.2 M
sodium acetate (pH 5.2). Two volumes of cold 100% ethanol
was added, and the solution was kept at -20°C overnight
and then centrifuged. The RNA pellet was suspended in
water, and the solution was adjusted to a final concentration
of 3 M sodium acetate (pH 6.0) and kept at 4°C for 40 min to
precipitate the mRNA and rRNA (K. F. Bastow, R. Prabhu,
and Y.-C. Cheng, Adv. Enzyme Regul., in press). The
supernatant was discarded after centrifugation, and the RNA
pellet was redissolved in water, followed by dilution with 2
volumes of 100% ethanol. RNA was precipitated overnight
at -20°C, pelleted by centrifugation at 10,000 rpm for 10
min, and then redissolved in water. The concentration of
RNA in the solution was determined by absorbance at 260
nm (24 absorbance units per mg of RNA) and adjusted to a
final concentration of 1,000 ,ugIml.
Agarose gel electrophoresis. A 1% agarose gel containing
6% Formalin and 1 ,ug of ethidium bromide per ml in running
buffer (20 mM morpholinepropanesulfonic acid, 5 mM sodi-
um acetate, pH 6.0, 1 mM EDTA, pH 7.0) was electropho-
resed for 6 h at 80 V.
Preparation- of samples for the agarose gel. Each sample
contained approximately 5 ,ug of RNA in 5 ,l of water, 2.5 ,ul
of 10x running buffer, 12.5 RI offormamide, and 5 ,u of 30%
Formalin. The samples were heated to 65°C for 10 min and
then cooled rapidly on ice. Before loading onto the gel, 12.5
RI of a solution of 50% sucrose and 0.4% bromophenol blue
was added.
Transfer of RNA to nitrocellulose paper. The RNA from
the electrophoresed gel was transferred to nitrocellulose
paper by a diffusion blotting method. The nitrocellulose
paper was placed in 20x SSPE buffer (3 M NaCl, 10 mM
KHPO4, pH 7.0, 1 mM EDTA) and blotted overnight. After
the RNA was blotted onto the paper it was dried for 15 min
under infrared light and then baked for 2 h in vacuo at 80°C.
Preparation and nick translation of DNA containing viral
DNA. A hybrid plasmid with the insertion of the HSV tk gene
at the BamHI site of E. coli pBR322 was kindly provided by
S. Bachenheimer, who obtained the plasmids from W.
Summers (7). This 3.5-kilobase (kb) BamHI fragment could
hybridize with at least one early mRNA (1.4 kb) coding for
viral tk and two late viral mRNA species (3.3 and 4.6 kb)
under the conditions we employed.
32P-labeled DNA was prepared by nick translation (19)
with [a-32P]dCTP to a specific activity of 1 x 108 to 3 x 108
cmp/,ug.
Hybridization. The nitrocellulose filters were prehybrid-
ized for 2 h at 65°C in 20 ml of 6x SSPE-0.5% SDS buffer in
a sealed plastic bag. The filters were then hybridized with 5
x 105 cpm of 32P-labeled DNA per ml, previously prepared
by nick translation.
Enzyme induction. Monolayers of HeLa S3 cells (5 x 106
cells) were infected at a multiplicity of 5 PFU per cell with
HSV-1. After 1 h of adsorption, the inoculum was removed,
and medium was added with or without S ,uM DHPG. After
virus had been allowed to replicate for various times, the
cells were scraped into the medium, pelleted by centrifuga-
tion at 2,000 rpm, and washed twice in PBS.
Cell pellets were disrupted by sonication in 500 ,ul of
extraction buffer (300 mM KH2PO4, pH 7.5, 2 mM dithio-
threitol, 1 mM EDTA, 1 mM PMSF, 0.2% Triton X-100, 10%
glycerol). Protein extracts were examined for thymidine
kinase, DNA polymerase, and DNase activity by previously
published methods (11, 14, 17). Thymidine kinase assays
were performed in the presence and absence of 40 ,uM 5-
bromovinyl deoxyuridine, which produces 50% inhibition of
virus thymidine kinase in this assay but has a negligible
effect on host enzyme. This allowed the detection of virus-
specific enzyme in the presence of host cell thymidine
kinase. Other conditions of the assay were the same as
previously described (14).
Protein electrophoresis and immunostaining. Samples con-
taining 10 ,ug of protein were precipitated with 5% trichloro-
acetic acid and then subjected to electrophoresis in 8.5%
SDS-polyacrylamide gels by the method of Laemmli and
Favre (13). Gels were placed between two sheets of nitrocel-
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FIG. 1. Effect of DHPG on virus DNA synthesis. Isopycnic
gradient centrifugation was performed on 32P-labeled uninfected
(Mock) and HSV-1-infected (KOS) HeLa S3 cells treated with
DHPG (0, 2, and 5 ,uM). Host DNA banded on the gradient at a
density of 1.50 g/cm3. Virus DNA banded on the gradient at a
density of 1.52 g/cm3. The details are described in the text.
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TABLE 1. Effects of DHPG on deoxynucleoside triphosphate
pool sizes in HSV-1-infected cellsa
Deoxynucleoside triphosphate (pmol)/106 cells)
DHPG
concn (,LM) dATP dCTP dTTP dGTP +
DHPGTP
0 38 12 60 12
1 34 39 175 39
5 39 41 165 53
a Details of the experiment are given in the text.
Towbin et al. (26). One sheet from each set was stained with
amido black to reveal protein patterns and to show molecu-
lar weight markers. The other sheet was used to detect HSV-
specific proteins by immunostaining procedures utilizing the
technique previously described (6). The primary antibodies
employed were prepared against lysates of HSV-1- and
HSV-2-infected cells and were obtained from a commercial
source. Utilizing this technique, only one protein band from
mock-infected HeLa S3 cells was detected. Virus-induced
proteins appearing during the course of infection were
correlated with those reported previously (12, 18).
Extraction and determination of deoxynucleoside triphos-
phates. HeLa S3 cells (ca. 4 x 106) were seeded in a 25-cm2
flask. Once the cells were attached, the growth medium was
removed and replaced with HSV-1 (3 PFU per cell) for a 1-h
adsorption period. The virus was then removed, and growth
medium containing various concentrations of DHPG was
added. After 6 h of exposure, the cells were collected, and
deoxynucleoside triphosphate pool sizes were determined as
previously described (27).
RESULTS
Effects of DHPG on DNA synthesis. HSV-1-infected cells
were exposed to DHPG at various concentrations after a 1-h
adsorption of virus. 32p was added 2 h postinfection, and
incubation was continued for 6 h. Cells were harvested and
prepared for Nal isopycnic centrifugation as described
above. The incorporation of radioactivity into viral DNA
was inhibited more than that into host DNA (Fig. 1). The
extracellular concentration of DHPG required to give 50%
inhibition of 32p incorporation into virus DNA was deter-
mined to be approximately 1 AM. An identical experiment
was performed using HSV-2-infected cells, and similar re-
sults were obtained (data not shown).
Effects of DHPG on deoxynucleoside triphosphate pool
sizes. Deoxynucleoside triphosphates were extracted from
HSV-1-infected cells which were exposed to various concen-
trations of DHPG for 6 h postinfection. Exposure to DHPG
did not result in a decrease of dATP, dCTP, or dTTP pool
sizes (Table 1). Since determination of dGTP pool size could
be affected by the presence of DHPGTP in cell extracts, this
was investigated by adding 100 nM DHPGTP to known
amounts of dGTP in the dGTP pool size assay employing E.
coli DNA polymerase. The results indicated greater incorpo-
ration of H label when DHPGTP was present (Table 2).
When the data were plotted, two lines with identical slopes
were obtained. The increment by which incorporation of 3H
label was increased by DHPGTP was equivalent to that
produced by similar concentrations of dGTP. Therefore, the
guanine nucleotide pools detected should be regarded as a
combination of dGTP and DHPGTP pools.
Formation of DHPGTP in virus-infected cells. The amount
of DHPGTP was determined in cells exposed to DHPG for 6
h after infection with HSV-1 or one of several phosphonofor-
TABLE 2. Increased [3H]dTTP incorporation in the presence of
DHPGTP during dGTP pool size determinationsa
dGTP cpm ± SD
concn (nM) Without DHPGTP + 100 nM DHPGTP
0 0 ± 202 1,422 ± 14
50 641 ± 68 3,005 ± 418
100 2,761 ± 13 2,909 ± 508
150 3,900 ± 62 5,122 ± 877
200 4,841 ± 101 6,802 ± 30
400 10,557 ± 711 11,886 ± 1252
a E. coli polymerase I was incubated at 37°C for 3.5 h with saturating
amounts of dCTP, dATP, and [3H]dTTP, utilizing calf thymus DNA in an
assay as described previously (27). Various concentrations of dGTP were
added with or without DHPGTP, as indicated. Results of one experiment are
presented; the experiment was repeated several times, and similar results
were obtained.
mic acid-resistant variants (Table 3). The amount of
DHPGTP formed in cells infected by the parental virus was
9.1 pmol per 106 cells, which was similar to the value
previously reported to us (2) and much less than those
reported by other investigators (10, 25). This could be due to
differences in the DHPG concentration employed, to differ-
ent strains of virus or host cells, or to other factors. Cells
infected with strain PFAr-1 produced the greatest amount of
DHPGTP (13.6 pmol per 106 cells), whereas those infected
with PFAr-5 produced the least DHPGTP (5.4 pmol per 106
cells).
Viral RNA synthesis in DHPG-treated infected cells. Cyto-
plasmic RNA was extracted from HSV-infected cells 3 and 6
h postinfection with or without addition of 5 ,uM DHPG. It
was possible to detect viral thymidine kinase and two late
protein mRNA species by hybridization with a recombinant
DNA probe which contained a HSV-1 DNA fragment.
DHPG did not cause a drastic change in the amount of either
thymidine kinase mRNA or late mRNA species (Fig. 2) as
determined by densitometric scanning of the autoradiogram
(data not shown).
Viral protein and enzyme induction in DHPG-treated cells.
Proteins and enzymes were extracted from HSV-1- and
HSV-2-infected cells with or without 5 ,uM DHPG treatment
at different times postinfection. After SDS-gel electrophore-
sis, the proteins were transferred onto a sheet of nitrocellu-
lose paper and immunostained with antiserum against HSV-
1 and HSV-2 proteins. There was no apparent difference in
the amounts and species of antibody-recognizable proteins
between DHPG-treated and control infected cells (Fig. 3).
Using HeLa S3 as host cells, the induction of virus thymidine
kinase, DNA polymerase, and DNase was examined. DHPG
TABLE 3. DHPGTP pools in cells infected with HSV-1 (KOS) or
phosphonoformic acid-resistant variantsa







a HeLa S3 cells were infected at a multiplicity of 3 PFU per cell with HSV-1
(KOS) or one of five phosphonoformic acid-resistant variant strains (5). After
exposure to 5 FM [3H]DHPG (1.2 Ci/mmol) for 6 h, cells were harvested and
extracted, and DHPGTP pools were determined by high-pressure liquid
chromatography as described previously (2).
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rlLj. 2. tEect of DHir on viral KNA syntnesis in HNV-I-
infected HeLa S3 cells. The preparation of the RNA, agarose gel
electrophoresis, blotting to nitrocellulose paper, nick translation,
and hybridization are described in the text. DHPG was added to the
growth medium, and samples were taken at 0, 3, and 6 h postinfec-
tion. C represents the RNA from control cells at the prescribed
times. D represents the RNA from cells treated with 5 ,uM DHPG.
did not inhibit the induction of these three enzymes in virus-
infected cells (Fig. 4).
DISCUSSION
DHPG could inhibit HSV DNA synthesis in infected cells
in a dose-dependent fashion. This observation is consistent
with those made by others (23). The concentration of extra-
cellular DHPG required to inhibit 50% of viral DNA synthe-
sis as measured by 32p incorporation is higher than that
reported when radioactive deoxynucleoside was employed
as the precursor for estimating DNA synthesis. Whether this
discrepancy is due to differences in the methodologies
employed or the cell line and virus used is unclear. Our
results are consistent with antiviral activity obtained for
DHPG in yield reduction assays (4).
The inhibition of viral DNA synthesis in virus-infected
cells could result from the lack of deoxynucleotides for DNA
synthesis, the inhibition of the synthesis of mRNA and
proteins which are required for DNA synthesis, or a direct
action on the viral DNA synthesis apparatus. In examining
the pool size of deoxynucleoside triphosphates, the results
clearly demonstrate that there are sufficient deoxynucleo-
side triphosphates for DNA synthesis. There is an observed
increase of some deoxynucleoside triphosphates which may
relate to the inhibition of viral DNA synthesis in DHPG-
treated cells. Thus the inhibition of viral DNA synthesis by
DHPG could not be due to deoxynucleotide depletion as the
result of the inhibition of some enzymes involved in deoxy-
nucleotide formation. As a probe, a recombinant plasmid
DNA containing a 3.5-kb virus DNA insert which could
hybridize with three mRNA species in virus-infected cells
was used, and the effect of DHPG on the synthesis of these
three virus mRNA species was examined. DHPG had no
drastic influence on the synthesis of either thymidine kinase
mRNA (1.4 kb) or the other two late mRNA species. Thus,
the general apparatus for the synthesis of virus mRNA_ does
not appear to be inhibited by DHPG. Since the other virus
mRNA species, which could not be detected by our probe,
may be inhibited in a selective fashion and also the viral
protein synthesis apparatus may involve guanosine nucleo-
FIG. 3. Effect of DHPG on induction of viral proteins. HeLa S3 monolayers were infected with HSV-1 or HSV-2 at 5 PFU per cell, and
medium was added with or without 5 ,uM DHPG after a 1-h adsorption period. At various times postinfection cell monolayers were extracted
as described in the text. Protein sample-s of IQ p.g each were precipitated with 5% trichloroacetic acid and electrophoresed in 8.5% SDS gels
along with molecular weight markers. Protein bands were blotted onto nitrocellulose sheets (26), and virus-specified proteins were detected
by immunological staining (6). Infected cell protein (ICP) and infected cell specific protein (ICSP) numbers were assigned according to relative
electrophoretic mobilities of protein bands reported in previous studies (12, 18).
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FIG. 4. Effect of DHPG on virus enzyme induction. HeLa S3
monolayers were infected with HSV-1 at 5 PFU per cell. After a 1-h
adsorption period, medium was added with or without 5 ,uM DHPG.
At various times postinfection monolayers were scraped, washed,
and examined for virus-induced thymidine kinase, DNA polymer-
ase, and DNase activity as described in the text.
tide as do those of other mammalian cells, we examined the
appearance of viral proteins, which are recognizable by
antiserum, and the enzymes involved in viral DNA synthesis
in infected cells treated with DHPG. No major difference in
mock-treated and DHPG-treated cells was observed. This
suggested that DHPG has no direct action on the viral
protein synthesis apparatus and that DHPG is likely to have
no effect on viral protein and RNA synthesis which may be
required for viral DNA synthesis.
The antiviral action of DHPG is likely to be due to its
action or that of its metabolites directly on the viral DNA
synthesis apparatus in infected cells. Since viral DNA poly-
merase is a possible target, we have recently examined the
effect of DHPGTP, a major metabolite of DHPG in infected
cells, on the DNA chain elongation reaction catalyzed by
HSV DNA polymerases isolated from cells infected by
several strains of HSV. These virus variants have the same
susceptibility to DHPG but different susceptibilities to acy-
clovir (4). There was a good correlation between the behav-
ior of acyclovir triphosphate toward a viral DNA polymerase
and the susceptibility of that virus to acyclovir (5), but no
correlation between the behavior of DHPGTP toward a viral
DNA polymerase and the susceptibility of that virus to
DHPG (9). The uptake of DHPG and the formation of
DHPGTP in cells infected by different virus variants were no
more than threefold different (Table 3). This suggests that
there are other reactions, in addition to the interaction of
DHPGTP and viral DNA polymerase-catalyzed DNA chain
elongation in the viral DNA synthesis apparatus, which may
be partly responsible for the antiviral action of DHPG. We
are now investigating such a possibility.
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